Progress in the study of combining Chinese and Western medicine to regulate immune imbalance affecting paediatric drug-resistant mycoplasma pneumonia

Corresponding author: BAI Xiao-Hong, lunwen200901@163.com

DOI: 10.12201/bmr.202608.00022

•  

  Abstract: s? Mycoplasma pneumoniae is a kind of lung inflammation caused by infection with Mycoplasma pneumoniae, which can involve bronchi, fine bronchioles, alveoli and interstitium of the lungs, and the clinical manifestations mainly include fever and cough. In more severe cases, persistent high fever, shortness of breath, cyanosis and wheezing may occur. In recent years, Mycoplasma pneumonia has shown a tendency to stage-wide outbreaks around the world, and reports about macrolide resistance have increased, and many scholars have conducted a series of studies on the regulation of immune imbalance by Chinese and Western medicine for the treatment of paediatric drug-resistant Mycoplasma pneumonia. In this paper, we review how Chinese and Western medical therapies regulate the immune imbalance from three perspectives: the pathogenesis of Mycoplasma pneumoniae, the mechanism of drug resistance, and the regulation of immune imbalance, so as to provide a new research direction for the treatment of paediatric drug-resistant Mycoplasma pneumonia.

  Key words: Chinese paediatrics; Mycoplasma pneumoniae pneumonia; macrolide resistance; immune imbalance

  Submit time: 9 August 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Pengli Yang¹, Gaofeng Pang¹, Zheng Guo. Visual Analysis of Traditional Chinese Medicine in the Treatment of Mycoplasma Pneumoniae Pneumonia Based on CiteSpace. 2026. doi: 10.12201/bmr.202604.00142

  YE Hongzhou, YUAN Chen. Risk factors of severe pneumonia in children with macrolide-resistant Mycoplasma pneumoniae pneumonia and the construction of prediction model. 2024. doi: 10.12201/bmr.202409.00021

  Lu jianliang, Feng yuan, Lu yanling. Analysis of clinical characteristics of severe mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202505.00038

  tangdongjing, wumeihui. Analysis of risk factors of bronchopneumonia and lobar pneumonia caused by mycoplasma pneumoniae. 2025. doi: 10.12201/bmr.202507.00035

  Li Feifan, Zhang shuitang. Impact of Mixed Infections and Antibiotic Resistance Genes on Clinical Features in Children with Mycoplasma pneumoniae Pneumonia. 2024. doi: 10.12201/bmr.202412.00025

  shen tengteng, xu huiqing, xu yuebo, zheng jishan. Efficacy analysis of doxycycline in the treatment of Mycoplasma Pneumoniae Pneumonia in children under 8 years old. 2025. doi: 10.12201/bmr.202509.00001

  changyanmei, yulijuan, 孟淑萍. The value of Mycoplasma pneumoniae RNA detection in the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. 2025. doi: 10.12201/bmr.202506.00025

  HUO Jie, HANG Feifei, XU Jing, GUAN Zheng. Value of serum IgE, LDH, and IL-18 in the early identification of refractory mycoplasma pneumoniae pneumonia in children. 2026. doi: 10.12201/bmr.202606.00009

  ZHANG Xiao-Hua, YANG Yi-Tong. Progress of community-acquired respiratory distress syndrome toxins in Mycoplasma pneumoniae infection in children. 2025. doi: 10.12201/bmr.202506.00057

  马亚鑫, ZHU Xiaowei, Li Shuqiong, Li Yunxiang, Sun Yonghong. MA Yaxin1, LI Shuqiong1, LI Yunxiang1, SUN Yonghong2▲. 2025. doi: 10.12201/bmr.202504.00073

• ID	Submit time	Number	Download
  1	2026-03-26	10.12201/bmr.202608.00022V1	Download

• Public  Anonymous  To author only Submit Comments